Home Topics Bioprocessing Evolved By Nature’s $120M Series C Equips Sustainable Activated Silk Scale-up for...

Evolved By Nature’s $120M Series C Equips Sustainable Activated Silk Scale-up for Global Impact

The Massachusetts-based biotech plans to upend the supply chains for leather, clothing, and personal care products that use synthetic and fossil fuel-derived chemicals.

By Jonathan D Grinstein, PhD

June 30, 2022

Evolved By Nature's chemistry platform is based on its patented Activated Silk technology, which is pure silk in liquid form. [Evolved By Nature]

Evolved By Nature—a biotechnology company that creates renewably sourced biomolecule solutions to human health needs—announced that it has closed a $120 million Series C financing round, which was led by Senator Investment Group and Teachers' Venture Growth (TVG). GEN Edge sat down with co-founder and CEO Gregory Altman, PhD, to learn more about Evolved By Nature’s inception and evolution . . .